Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pancreatic Neoplasms × Biopsy × Clear all

Phase

Phase 2 9 Phase 1 7 Phase NA 3 Phase EARLY_PHASE1 2 Phase 1/2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 3 Burkitt Lymphoma 3 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Leukemia, Myelomonocytic, Chronic 2 Ganglioneuroblastoma 2 Breast Neoplasms 2 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Hepatoblastoma 1

Interventions

Gemcitabine 63 Fluorouracil 28 Leucovorin 18 Oxaliplatin 17 130-nm albumin-bound paclitaxel 12 Capecitabine 11 Irinotecan 9 Albumin-Bound Paclitaxel 9 irinotecan sucrosofate 6 Radiotherapy 6 folfirinox 4 Taxes 4 Erlotinib Hydrochloride 4 rubitecan 3 Surgical Procedures, Operative 3 Specimen Handling 3 Pancreaticojejunostomy 3 Neoadjuvant Therapy 3 Drug Therapy 3 Cisplatin 3 ruxolitinib 2 masitinib 2 dehydroftorafur 2 Saline Solution 2 Paclitaxel 2 Fentanyl 2 Chemotherapy, Adjuvant 2 Bevacizumab 2 Acupuncture Therapy 2 viscum album peptide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958328 2026-02-02

LAP100

NRG Oncology

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡